GLAUKOS CORP (GKOS) Fundamental Analysis & Valuation

NYSE:GKOS • US3773221029

Current stock price

101.43 USD
-1.79 (-1.73%)
Last:

This GKOS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GKOS Profitability Analysis

1.1 Basic Checks

  • In the past year GKOS has reported negative net income.
  • In the past year GKOS has reported a negative cash flow from operations.
  • GKOS had negative earnings in each of the past 5 years.
  • GKOS had negative operating cash flow in 4 of the past 5 years.
GKOS Yearly Net Income VS EBIT VS OCF VS FCFGKOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • GKOS has a Return On Assets of -21.01%. This is comparable to the rest of the industry: GKOS outperforms 48.37% of its industry peers.
  • The Return On Equity of GKOS (-28.60%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.01%
ROE -28.6%
ROIC N/A
ROA(3y)-16.78%
ROA(5y)-12.99%
ROE(3y)-25.62%
ROE(5y)-20.8%
ROIC(3y)N/A
ROIC(5y)N/A
GKOS Yearly ROA, ROE, ROICGKOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • Looking at the Gross Margin, with a value of 77.97%, GKOS belongs to the top of the industry, outperforming 89.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GKOS has grown nicely.
  • GKOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y5.66%
GKOS Yearly Profit, Operating, Gross MarginsGKOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. GKOS Health Analysis

2.1 Basic Checks

  • GKOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GKOS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, GKOS has more shares outstanding
  • Compared to 1 year ago, GKOS has a worse debt to assets ratio.
GKOS Yearly Shares OutstandingGKOS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
GKOS Yearly Total Debt VS Total AssetsGKOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • GKOS has an Altman-Z score of 14.44. This indicates that GKOS is financially healthy and has little risk of bankruptcy at the moment.
  • GKOS has a Altman-Z score of 14.44. This is amongst the best in the industry. GKOS outperforms 94.57% of its industry peers.
  • GKOS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • GKOS's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. GKOS outperforms 65.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 14.44
ROIC/WACCN/A
WACC10.09%
GKOS Yearly LT Debt VS Equity VS FCFGKOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.69 indicates that GKOS has no problem at all paying its short term obligations.
  • GKOS has a Current ratio of 4.69. This is in the better half of the industry: GKOS outperforms 72.28% of its industry peers.
  • GKOS has a Quick Ratio of 4.06. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
  • GKOS has a Quick ratio of 4.06. This is in the better half of the industry: GKOS outperforms 73.37% of its industry peers.
Industry RankSector Rank
Current Ratio 4.69
Quick Ratio 4.06
GKOS Yearly Current Assets VS Current LiabilitesGKOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. GKOS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 52.63% over the past year.
  • The Revenue has grown by 32.33% in the past year. This is a very strong growth!
  • The Revenue has been growing by 17.66% on average over the past years. This is quite good.
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)32.33%
Revenue growth 3Y21.5%
Revenue growth 5Y17.66%
Sales Q2Q%35.66%

3.2 Future

  • Based on estimates for the next years, GKOS will show a very strong growth in Earnings Per Share. The EPS will grow by 47.14% on average per year.
  • GKOS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.73% yearly.
EPS Next Y36.78%
EPS Next 2Y57.52%
EPS Next 3Y54.97%
EPS Next 5Y47.14%
Revenue Next Year22.72%
Revenue Next 2Y25.07%
Revenue Next 3Y26.87%
Revenue Next 5Y24.73%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GKOS Yearly Revenue VS EstimatesGKOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
GKOS Yearly EPS VS EstimatesGKOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

1

4. GKOS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GKOS. In the last year negative earnings were reported.
  • Also next year GKOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GKOS Price Earnings VS Forward Price EarningsGKOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GKOS Per share dataGKOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • GKOS's earnings are expected to grow with 54.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.52%
EPS Next 3Y54.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GKOS Dividend Analysis

5.1 Amount

  • GKOS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GKOS Fundamentals: All Metrics, Ratios and Statistics

GLAUKOS CORP

NYSE:GKOS (3/19/2026, 9:37:59 AM)

101.43

-1.79 (-1.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners100.27%
Inst Owner Change0.99%
Ins Owners3.43%
Ins Owner Change1.44%
Market Cap5.89B
Revenue(TTM)507.44M
Net Income(TTM)-187.69M
Analysts83.64
Price Target137.48 (35.54%)
Short Float %5.15%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.39%
Min EPS beat(2)-39.91%
Max EPS beat(2)39.14%
EPS beat(4)3
Avg EPS beat(4)12.06%
Min EPS beat(4)-39.91%
Max EPS beat(4)39.14%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)7
Avg EPS beat(12)5.88%
EPS beat(16)10
Avg EPS beat(16)1.95%
Revenue beat(2)2
Avg Revenue beat(2)4.86%
Min Revenue beat(2)2.88%
Max Revenue beat(2)6.84%
Revenue beat(4)4
Avg Revenue beat(4)4.27%
Min Revenue beat(4)2.01%
Max Revenue beat(4)6.84%
Revenue beat(8)8
Avg Revenue beat(8)4.29%
Revenue beat(12)12
Avg Revenue beat(12)4.22%
Revenue beat(16)16
Avg Revenue beat(16)4.37%
PT rev (1m)1.56%
PT rev (3m)13.13%
EPS NQ rev (1m)-40.65%
EPS NQ rev (3m)-56.91%
EPS NY rev (1m)-63.94%
EPS NY rev (3m)-126.28%
Revenue NQ rev (1m)4.01%
Revenue NQ rev (3m)3.37%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.61
P/FCF N/A
P/OCF N/A
P/B 8.98
P/tB 13.16
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS8.74
BVpS11.3
TBVpS7.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.01%
ROE -28.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.97%
FCFM N/A
ROA(3y)-16.78%
ROA(5y)-12.99%
ROE(3y)-25.62%
ROE(5y)-20.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y5.66%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.32%
Cap/Sales 4.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.69
Quick Ratio 4.06
Altman-Z 14.44
F-Score3
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)42.14%
Cap/Depr(5y)76.69%
Cap/Sales(3y)4.29%
Cap/Sales(5y)7.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y36.78%
EPS Next 2Y57.52%
EPS Next 3Y54.97%
EPS Next 5Y47.14%
Revenue 1Y (TTM)32.33%
Revenue growth 3Y21.5%
Revenue growth 5Y17.66%
Sales Q2Q%35.66%
Revenue Next Year22.72%
Revenue Next 2Y25.07%
Revenue Next 3Y26.87%
Revenue Next 5Y24.73%
EBIT growth 1Y19.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.11%
EBIT Next 3Y72.31%
EBIT Next 5YN/A
FCF growth 1Y42.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.88%
OCF growth 3YN/A
OCF growth 5YN/A

GLAUKOS CORP / GKOS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GLAUKOS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to GKOS.


What is the valuation status for GKOS stock?

ChartMill assigns a valuation rating of 1 / 10 to GLAUKOS CORP (GKOS). This can be considered as Overvalued.


How profitable is GLAUKOS CORP (GKOS) stock?

GLAUKOS CORP (GKOS) has a profitability rating of 2 / 10.